Zhejiang Huakang Pharmaceutical Co., Ltd.
Shanghai Stock Exchange 605077.SS
Zhejiang Huakang Pharmaceutical Co., Ltd. Shareholders' Equity for the year ending December 31, 2023: USD 435.15 M
Zhejiang Huakang Pharmaceutical Co., Ltd. Shareholders' Equity is USD 435.15 M for the year ending December 31, 2023, a 13.07% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
-
Zhejiang Huakang Pharmaceutical Co., Ltd. Shareholders' Equity for the year ending December 31, 2022 was USD 384.85 M, a 0.45% change year over year.
-
Zhejiang Huakang Pharmaceutical Co., Ltd. Shareholders' Equity for the year ending December 31, 2021 was USD 383.13 M, a 166.18% change year over year.
-
Zhejiang Huakang Pharmaceutical Co., Ltd. Shareholders' Equity for the year ending December 31, 2020 was USD 143.93 M, a 46.37% change year over year.
-
Zhejiang Huakang Pharmaceutical Co., Ltd. Shareholders' Equity for the year ending December 31, 2019 was USD 98.34 M, a 53.39% change year over year.
Key data
| Date | Shareholders' Equity | Minority Interest | Total Equity | Total Stockholders Equity and Liabilities |
|---|
Market news
Loading...
Don’t Miss A Beat
Shanghai Stock Exchange: 605077.SS
| CEO | Mr. Deshui Chen |
| IPO Date | Feb. 9, 2021 |
| Location | China |
| Headquarters | No.18, Huagong Road |
| Employees | 1,350 |
| Sector | Consumers Staples |
| Industries | |
Description
Zhejiang Huakang Pharmaceutical Co., Ltd. engages in the research, production, and sale of polyols worldwide. Its products include xylitol, a polyol with close to sugar sweetness; sorbitol, a sugar alcohol being white crystal powder; maltitol, a sugar alcohol; xylose that is used in xylitol production; and L-arabinos, which can be used as sucrose replacement or additives. The company is based in Kaihua County, China.
Key trends
Past 5 years
StockViz Staff
February 2, 2025
Any question? Send us an email